Back to AI Alyeska Investment Group, L.P.

PCVXPCVX

Showing 8 of 17 quarters

Position history for AIAlyeska Investment Group, L.P.'s holdings in Vaxcyte, Inc.

Yes. Alyeska Investment Group holds 362,272 shares of PCVX (Vaxcyte), worth $21.1M, as of its Q2 2026 13F filing. It reduced the position by 73,309 shares (-16.8%) from Q1 2026. Alyeska Investment Group has held PCVX since Q3 2024, across 8 quarterly 13F filings. PCVX is 0.1% of Alyeska Investment Group's reported 13F portfolio.

Current Value

$21.1M

Current Shares

362,272

Total Value Change

-$3.9M

Total Shares Change

+143,441

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
362,272
-16.8%
$21.1M0.1%$58.13
0
2026-Q1
Increased
435,581
+78.0%
$25.3M0.1%$59.82
44
2025-Q4
Unchanged
244,775
0.0%
$11.3M0.0%$45.41
0
2025-Q3
Unchanged
244,775
0.0%
$8.8M0.0%$34.65
0
2025-Q2
Increased
244,775
+48.7%
$8M0.0%$32.58
38
2025-Q1
Decreased
164,640
-16.7%
$6.2M0.0%$69.46
0
2024-Q4
Decreased
197,585
-9.7%
$16.2M0.1%$81.99
0
2024-Q3
New
218,831
—
$25M0.1%$113.14
47

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used